CAS 88183-82-8
:Guanosine,2'-désoxy-3',5'-O-[1,1,3,3-tétrakis(1-méthyléthyl)-1,3-disiloxanédiyl]-
3',5'-O-[Tetrakis(1-methylethyl)-1,3-disiloxanediyl]guanosine-13C,15N2
CAS :Produit contrôléApplications Used in the preparation of nucleotide analogs.
Formule :CC21H3915N2N3O6Si2Couleur et forme :NeatMasse moléculaire :528.7252'-Deoxy-3',5'-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]guanosine-13C15N2
CAS :Produit contrôléApplications 2'-Deoxy-3',5'-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]guanosine-13C15N2 is an isotope labelled intermediate in the preparation of nucleotide analogs.
References Robins, M. J., et al.: J. Am. Chem. Soc., 105, 4059 (1983);Formule :C21CH39N3N2O5Si2Couleur et forme :NeatMasse moléculaire :512.733',5'-O-[Tetrakis(1-methylethyl)-1,3-disiloxanediyl]-guanosine
CAS :3',5'-O-[Tetrakis(1-methylethyl)-1,3-disiloxanediyl]-guanosine is a nucleoside phosphoramidite that is synthesized by the reaction of 3',5'-O-[Tetrakis(trimethylsiloxy)silyl]guanosine with tetrakis(1-methylethyl) siloxane. It is a novel monophosphate analogue of guanosine and has antiviral, anticancer and activator properties. 3',5'-O-[Tetrakis(1-methylethyl)-1,3-disiloxanediyl]-guanosine is not toxic to cells and can be used in the treatment of cancer.
Formule :C22H39N5O6Si2Degré de pureté :Min. 95%Masse moléculaire :525.75 g/mol


